Home›People›Demetrios Kydonieus
DK

Demetrios Kydonieus

Director at Invea Therapeutics.

Director
Updated Oct 27, 2026·Latest SEC filing Dec 10, 2025·Suggest an edit

About Demetrios Kydonieus

Demetrios Kydonieus is a director at Invea Therapeutics.

Demetrios Kydonieus first appears on SEC filings in 2022.

Experience

This experience comes from SEC filings. The years are when the filings name Demetrios Kydonieus in the role, so the role may have started earlier or lasted longer.

Invea Therapeutics, Inc
Director
2022 – 2025 · Guilford, CT

Key Colleagues at Startups

The people Demetrios Kydonieus works with at each company, as listed on that company's latest Form D.

Invea Therapeutics, Inc · Form D, Dec 10, 2025
AK
Aman Kant
President
SA
Salvatore Alesci
Chief Scientific Officer
MA
Michael Aiello
Chief Financial Officer
SO
Shunichiro "Steve" Okada
Chief Medical Officer
KB
Kerrie Brady
Director
KN
Krishnan Nandabalan
Chief Executive Officer and Chairman

Sources

  1. SECInvea Therapeutics, Inc Form D, filed Dec 10, 2025